NASDAQ: DOCU

DOCUSIGN, INC.

CIK 0001261333 · Prepackaged Software

Large Revenue $3.2B Assets $4.0B as of Jul 16, 2026

Each report below shows a 3-bullet preview. Free accounts read 3 full reports a month — narrative summary, section diffs, and EDGAR-cited quotes.

Sign up free

Want to see a complete report first? Today's free report (THRM 10-Q) is open in full — no account needed.

10-Q Filed Jun 5, 2026 · Period ending Apr 30, 2026

DocuSign Q1 revenue up 9%, operating income doubles; IAM platform reaches 12.6% of ARR

5 material changes detected. Sign up free to read the summary.

8-K Filed Jun 4, 2026 · Period ending Jun 4, 2026

DocuSign reports Q1 FY2027 financial results for quarter ended April 30, 2026

2 material changes detected. Sign up free to read the summary.

Partner

Trade DOCU commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

8-K Filed Jun 3, 2026 · Period ending Jun 1, 2026

DocuSign stockholders approve annual say-on-pay votes and reelect three directors

5 material changes detected. Sign up free to read the summary.

8-K Filed May 6, 2026 · Period ending May 2, 2026

DocuSign appoints Redis CEO Rowan Trollope to Board of Directors

3 material changes detected. Sign up free to read the summary.

10-K Filed Mar 18, 2026 · Period ending Jan 31, 2026

DocuSign expands SF headquarters lease, adds AI governance to cybersecurity framework

5 material changes detected. Sign up free to read the summary.

10-Q Filed Dec 5, 2025 · Period ending Oct 31, 2025

Summary not yet generated.

10-Q Filed Jun 6, 2025 · Period ending Apr 30, 2025

Summary not yet generated.

10-K Filed Mar 18, 2025 · Period ending Jan 31, 2025

Summary not yet generated.

Latest financial statements

From 10-Q filed Jun 5, 2026 (period ending Apr 30, 2026). SEC XBRL (companyfacts) — not generated by the model.

SEC XBRL

Consolidated Statements of Operations (Unaudited)

Description Q1 ended Apr 30, 2026 Q1 ended Apr 30, 2025
Revenue:
Total revenue / net sales 830.2 763.7
Cost of revenue / cost of sales 171.3 157.3
Gross profit 659.0 606.4
Operating expenses:
Sales and marketing 296.2 296.4
Research and development 159.6 159.4
General and administrative 91.9 90.3
Total operating expenses 547.7 546.1
Operating income 111.3 60.3
Interest expense 0.6 0.5
Other income/(expense), net 7.0 14.0
Income before income taxes 117.8 73.8
Income tax expense/(benefit) 39.6 1.7
Net income 78.2 72.1
Basic earnings per share 0.40 0.35
Diluted earnings per share 0.40 0.34

Consolidated Balance Sheets (Unaudited)

Description Apr 30, 2026 Apr 30, 2025
Current assets:
Cash and equivalents 548.0 657.4
Short-term investments 266.2 291.3
Accounts receivable, net 300.7 307.6
Prepaid expenses and other current assets 132.7 111.2
Total current assets 1,256 1,377
Property, plant and equipment, net 387.9 310.1
Operating lease right-of-use assets, net 160.1 115.4
Finite-lived intangible assets, net 56.7 69.5
Goodwill 459.1 455.3
Deferred income taxes and other assets 805.1 844.8
Other long-term assets 859.4 775.2
TOTAL ASSETS 3,984 3,947
Current liabilities:
Accounts payable 24.0 24.6
Current portion of operating lease liabilities 16.1 21.8
Accrued liabilities 108.0 101.2
Deferred revenue, current 1,565 1,423
Other current liabilities 175.6 171.0
Total current liabilities 1,889 1,741
Operating lease liabilities 167.3 111.1
Deferred income taxes and other liabilities 24.2 22.4
Other long-term liabilities 84.2 57.7
Total liabilities 2,164 1,933
Shareholders' equity:
Common stock 0.02 0.02
Capital in excess of stated value 3,921 3,435
Accumulated other comprehensive income (loss) (4.0) (18.2)
Retained earnings (deficit) (2,097) (1,399)
Treasury stock 3.2
Total shareholders' equity 1,820 2,015
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY 3,984 3,947

Consolidated Statements of Cash Flows (Unaudited)

Description Q1 ended Apr 30, 2026 Q1 ended Apr 30, 2025
Operating Activities:
Net cash from operating activities 321.7 251.4
Investing Activities:
Net cash from investing activities (39.2) (24.9)
Financing Activities:
Net cash from financing activities (334.4) (223.5)
Net increase/(decrease) in cash (52.5) 12.9

Amounts in millions USD; EPS as reported. Line labels are presentation-friendly mappings of filer XBRL tags — not a re-audit of the full statements. Use EDGAR for interactive notes and detail. Interactive statements & notes on EDGAR ↗

View AI report for this filing